Compare CWH & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CWH | TBPH |
|---|---|---|
| Founded | 1966 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail-Auto Dealers and Gas Stations | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 2016 | 2013 |
| Metric | CWH | TBPH |
|---|---|---|
| Price | $6.71 | $15.22 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 6 |
| Target Price | $15.89 | ★ $17.80 |
| AVG Volume (30 Days) | ★ 3.8M | 832.2K |
| Earning Date | 04-28-2026 | 03-19-2026 |
| Dividend Yield | ★ 7.43% | N/A |
| EPS Growth | N/A | ★ 279.13 |
| EPS | ★ 3.99 | 2.06 |
| Revenue | ★ $4,792,017,000.00 | $15,386,000.00 |
| Revenue This Year | $4.63 | $9.51 |
| Revenue Next Year | $5.85 | N/A |
| P/E Ratio | ★ $1.69 | $7.22 |
| Revenue Growth | ★ 11.83 | N/A |
| 52 Week Low | $5.70 | $7.90 |
| 52 Week High | $19.64 | $21.03 |
| Indicator | CWH | TBPH |
|---|---|---|
| Relative Strength Index (RSI) | 34.22 | 47.01 |
| Support Level | N/A | $13.41 |
| Resistance Level | $18.18 | $19.04 |
| Average True Range (ATR) | 0.45 | 0.40 |
| MACD | 0.17 | 0.28 |
| Stochastic Oscillator | 52.88 | 99.52 |
Camping World Holdings Inc is a retailer of RVs and related products and services. The company has two reportable segments; the Good Sam Services and Plans segment, which includes the sale of emergency roadside assistance plans; commissions on property and casualty insurance programs; travel assist programs; extended vehicle service contracts; vehicle financing and refinancing assistance; consumer shows and events; and consumer publications and directories; and the RV and Outdoor Retail segment, which generates maximum revenue and includes the sale of new and used RVs; commissions on the finance and insurance contracts related to the sale of RVs; the sale of RV service and collision work; the sale of RV parts, accessories, business to business distribution of RV furniture, etc.
Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).